Use of two calcium concentrations in hemodialysis: Report of a 20-year clinical experience

Clinical Nephrology

Volumn 71, Issue 3, 2009, Pages 296-305

  Seyffart, G ^a,c,d   Schulz, T ^b   Stiller, S ^c  

^a Dialysis Center Bad Homburg   (Germany)

^b Markus Hospital   (Germany)

^c Interneph Aachen   (Germany)

^d NONE   (Germany)

Author keywords

Calcium homeostasis; Calcium containing and calcium free phosphate binders; Dialysate calcium; End stage renal disease; Secondary hyperparathyroidism

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM MAGNESIUM); ALFACALCIDOL; ALUMINUM HYDROXIDE; BICARBONATE; CALCITRIOL; CALCIUM; CALCIUM ACETATE; CALCIUM CARBONATE; CITRATE CALCIUM; LANTHANUM CARBONATE; MAGNESIUM CARBONATE; OSVAREN; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; SEVELAMER; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE; DIALYSIS FLUID;

ACIDOSIS; ADULT; ARTICLE; BONE PAIN; CALCIUM BLOOD LEVEL; CALCIUM DEFICIENCY; CALCIUM HOMEOSTASIS; CALCIUM METABOLISM; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; DIALYSATE; ELECTROLYTE DISTURBANCE; ENTERIC COATED TABLET; FEMALE; FRACTURE; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; INCIDENCE; KIDNEY CALCIFICATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PARATHYROIDECTOMY; RENAL OSTEODYSTROPHY; SECONDARY HYPERPARATHYROIDISM; SURVIVAL RATE; BLOOD; CHEMISTRY; HISTORY; HOSPITALIZATION; LONGITUDINAL STUDY; PROPORTIONAL HAZARDS MODEL; RENAL REPLACEMENT THERAPY; SURVIVAL; TREATMENT OUTCOME;

CALCIUM; DIALYSIS SOLUTIONS; FEMALE; HISTORY, 17TH CENTURY; HUMANS; HYPERPARATHYROIDISM, SECONDARY; INCIDENCE; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RENAL OSTEODYSTROPHY; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 65449172354     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP71296     Document Type: Article

References (19)

1. (ERA-EDTA) ERA. European best practice guidelines for hemodialysis (Part 1). Nephrol Dial Transplant. 2002; 17 (Suppl. 7): 1-110.
2. (ERA-EDTA) ERA. Registry: 2005 Annual Report. Amsterdam, The Netherlands: Academic Medical Center, Department of Medical Information. 2007. p. 1-129.
3. Argilés A, Kerr PG, Canaud B, Flavier JL, Mion C. Calcium kinetics and the long-term effects of lowering dialysate calcium concentration. Kidney Int. 1993; 43: 630-640.
4. Bloembergen WE. Cardiac disease in chronic uremia: epidemiology. Adv Ren Replace Ther. 1997; 4: 185-193.
5. Clase CM, Norman GL, Beecroft LM, Curchill DN. Albumin-corrected calcium and ionized calcium in stable haemodialysis patients. Nephrol Dial Transplant. 2000; 15: 1841-1846.
6. Foley RN, Murray AM, Li S et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 2005; 16: 489-495.
7. Goransson LG, Skadberg O, Bergrem H. Albumin-corrected or ionized calcium in renal failure?What to measure? Nephrol Dial Transplant. 2005; 20: 2126-2129.
8. Ledebo I. Ultrapure dialysis fluid - direct and indirect benefits in dialysis therapy. Blood Purif. 2004; 22 (Suppl. 2): 20-25.
9. Lindsay RM, Alhejaili F, Nesrallah G et al. Calcium and phosphate balance with quotidian hemodialysis. Am J Kidney Dis. 2003; 42 (Suppl. 1): 24-29.
10. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2003; 42 (Suppl. 3): S12-S28.
11. National Kidney Foundation. K/DOQI Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003; 42 (Suppl. 3): S1-S202.
12. Ritz E. Managing mineral balance in end-stage renal disease. Nephrol Dial Transplant. 2004; 19 (Suppl. 1): i1-i3.
13. Seyffart G, Ensminger A, Scholz R. Increase of body mass during long-term bicarbonate hemodialysis. Kidney Int. 1987; (Suppl. 22): S174-S177.
14. Sheikh MS, Santa Ana CA, Nicar MJ, Schiller LR, Fordtran JS. Gastrointestinal absorption of calcium from milk and calcium salts. N Engl J Med. 1987; 317: 532-536.
15. Slatopolsky E, Weerts C, Lopez-Hilker S et al. Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis. N Engl J Med. 1986; 315: 157-161.
16. Toussaint N, Cooney P, Kerr PG. Review of dialysate calcium concentration in hemodialysis. Hemodial Int. 2006; 10: 326-337.
17. United States Renal Data System (USRDS). AR VI. Survival and mortality. Patient characteristics and mortality. Am J Kidney Dis. 1990; 16 (Suppl. 2): S44-S52.
18. United States Renal Data System (USRDS). AR VI. Causes of death. Am J Kidney Dis. 1999; 34 (Suppl. 1): S87-S94.
19. Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant. 2005; 20: 1048-1056.